Every 10-Q that Alphatec Holdings, Inc. (ATEC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ATEC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATEC filings page.
Alphatec Holdings generated $213.5 million in revenue from products and services in the quarter ended June 30 2026, up 15% from a year earlier, and $405.6 million for the first half, up 14%. Higher product volume from a growing surgeon user base and broader product portfolio lifted gross profit to $154.1 million. The operating loss narrowed substantially to $1.9 million from $13.1 million, while net loss improved to $25.8 million from $41.1 million.
Cash flow from operating activities turned stronger at $21.8 million for the first six months, though cash and cash equivalents declined to $118.7 million as the company invested $42.6 million in property, equipment and intangibles and used cash for debt transactions. Total debt principal was $685.0 million, including $405.0 million of 0.75% Convertible Senior Notes due 2030 and new $175.0 million JP Morgan term debt plus $40.0 million drawn on a revolver used to refinance prior facilities. Stockholders’ equity moved to a deficit of $12.1 million, and subsequent to quarter-end the remaining $63.3 million of 2026 convertible notes was repaid in cash.
Alphatec Holdings reported Q1 2026 revenue of $192.1 million, up 14% from $169.2 million a year earlier, driven by higher procedure volume and broader adoption of its spine surgery portfolio. Net loss narrowed to $33.9 million from $51.9 million as litigation expenses fell sharply.
Operating loss improved to $22.6 million versus $44.3 million, while interest expense increased due to the 0.75% Convertible Senior Notes due 2030. Cash and cash equivalents were $139.9 million and operating cash flow was modestly positive at $1.3 million.
Total debt included $405.0 million of 2030 convertible notes, $63.3 million of 2026 convertible notes, a $200.0 million Braidwell term loan and a $15.1 million revolving credit balance. After quarter-end, Alphatec replaced the Braidwell and MidCap facilities with a new $175.0 million term loan and $125.0 million revolver from JP Morgan maturing in 2031.
Alphatec Holdings (ATEC) reported third-quarter results for the period ended September 30, 2025. Revenue from products and services was $196.5 million, up from $150.7 million a year ago. Gross profit was $137.3 million. Operating loss narrowed to $15.9 million from $33.7 million, while net loss was $28.6 million, or $0.19 per share, compared with $39.6 million, or $0.28 per share, last year.
For the first nine months of 2025, revenue reached $551.2 million versus $434.8 million in 2024. Net cash provided by operating activities was $24.5 million, a swing from $55.2 million used in the prior year period. Cash and cash equivalents were $155.7 million.
The company completed key financing actions: issued $405.0 million of 0.75% Senior Convertible Notes due 2030 (net proceeds ~$392.9 million), entered into $42.5 million capped call transactions, and repurchased 80% of its 0.75% Notes due 2026 for $268.4 million, recording a $17.6 million extinguishment loss. As of quarter-end, long-term debt (net of current portion) was $495.0 million, including a $200.0 million Braidwell term loan and $15.0 million outstanding on the revolving credit facility. Total stockholders’ equity improved to $11.5 million from a deficit at year-end 2024.